Taylor Aiken Selected Research

3'-deoxy-5-(cyanine dye 5)uridine 5'-trisphosphate

7/2018

Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taylor Aiken Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 07/2018
1	Venous Thromboembolism 01/2022
1	Fistula 11/2020
1	Pain (Aches) 11/2020
1	Postoperative Pain 11/2020
1	Neoplasm Metastasis (Metastasis) 07/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Hepatitis C 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018

Drug/Important Bio-Agent (IBA)

1	Opioid Analgesics (Opioids)IBA 11/2020
1	3'-deoxy-5-(cyanine dye 5)uridine 5'-trisphosphateIBA 07/2018
1	Gemcitabine FDA Link 07/2018
1	Epidermal Growth Factor (EGF)IBA 07/2018
1	AdiponectinIBA 01/2018

Therapy/Procedure

2	Therapeutics 12/2020 - 07/2018
1	Cystectomy 01/2022
1	Esophagectomy 01/2022
1	Colectomy 01/2022
1	Proctectomy 01/2022
1	Patient Readmission 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Gastrectomy 01/2022
1	Hysterectomy 01/2022
1	Length of Stay 01/2022
1	Pancreatectomy 01/2022
1	Cytoreduction Surgical Procedures 12/2020
1	Hyperthermic Intraperitoneal Chemotherapy 12/2020
1	Anesthesia 11/2020
1	Hemorrhoidectomy 11/2020
1	Drug Therapy (Chemotherapy) 07/2018
1	Liver Transplantation 01/2018